FIELD: chemistry.
SUBSTANCE: invention relates to a composition for use in boron-neutron capture therapy containing borylated amino acids. Borylated amino acids have the following chemical structure:
where E = CONHB12H11 and X=H. Also disclosed are kits and standard dosage forms containing said composition.
EFFECT: disclosed composition can be administered to patients as a neutron capture agent to provide a method of treating cancer, immunological disorders and other diseases using a boron-neutron capture therapy agent.
8 cl, 14 dwg, 1 tbl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
BORON COMPOUNDS EFFECTIVE IN BORON NEUTRON CAPTURE THERAPY | 2006 |
|
RU2423368C2 |
BORON-NEUTRON CAPTURE THERAPY SYSTEM AND METHOD OF CREATING TREATMENT PLAN THEREFOR | 2021 |
|
RU2824926C1 |
BORON-CONTAINING COMPOUND | 2017 |
|
RU2739198C2 |
BIODEGRADABLE NANO-CARRIER(S) (BPMOs) FOR NEUTRON CAPTURE THERAPY AND ITS METHODS | 2019 |
|
RU2780888C2 |
RADIATION EXPOSURE SYSTEM AND METHOD OF CONTROLLING IT | 2021 |
|
RU2820986C1 |
METHOD FOR DETERMINING ABSORBED DOSE FROM THERMAL NEUTRONS IN BORON-NEUTRON CAPTURE THERAPY OF MALIGNANT TUMORS | 2019 |
|
RU2709682C1 |
SYSTEM FOR GENERATING NEUTRON BEAM | 2013 |
|
RU2540124C2 |
METHOD OF MEASURING ABSORBED DOSE IN BORON NEUTRON CAPTURE THERAPY OF MALIGNANT TUMORS | 2015 |
|
RU2606337C1 |
NEUTRON-GENERATING TARGET | 2015 |
|
RU2610301C1 |
CARBORANYLPORPHYRINE AND USE THEREOF | 2007 |
|
RU2477161C2 |
Authors
Dates
2024-05-06—Published
2020-03-04—Filed